Yue Shao

709 total citations
26 papers, 373 citations indexed

About

Yue Shao is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yue Shao has authored 26 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yue Shao's work include Aortic Disease and Treatment Approaches (5 papers), Aortic aneurysm repair treatments (5 papers) and RNA modifications and cancer (4 papers). Yue Shao is often cited by papers focused on Aortic Disease and Treatment Approaches (5 papers), Aortic aneurysm repair treatments (5 papers) and RNA modifications and cancer (4 papers). Yue Shao collaborates with scholars based in China, United Kingdom and United States. Yue Shao's co-authors include Chenghai Zhao, Na Xin, Wei Wang, Qianqian Zheng, Jian Gao, Dan Dong, Biao Wang, Ning Wei, Mingli Sun and Wei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Yue Shao

24 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yue Shao China 12 145 104 90 80 70 26 373
Annabella Di Mauro Italy 12 158 1.1× 155 1.5× 90 1.0× 49 0.6× 41 0.6× 41 401
Cho‐Yun Chung South Korea 13 174 1.2× 90 0.9× 66 0.7× 55 0.7× 52 0.7× 20 362
Zhen Zhu China 12 268 1.8× 113 1.1× 124 1.4× 61 0.8× 97 1.4× 23 464
Clelia Donisi Italy 7 152 1.0× 225 2.2× 102 1.1× 71 0.9× 32 0.5× 28 395
Haibo Mou China 10 128 0.9× 117 1.1× 71 0.8× 63 0.8× 77 1.1× 29 362
Renpin Chen China 14 177 1.2× 120 1.2× 83 0.9× 87 1.1× 86 1.2× 27 505
Xukui Zhang China 8 118 0.8× 104 1.0× 74 0.8× 137 1.7× 62 0.9× 8 358
Naveen K Somanna United States 10 211 1.5× 63 0.6× 56 0.6× 69 0.9× 55 0.8× 14 454
Jieying Yang China 11 174 1.2× 63 0.6× 113 1.3× 99 1.2× 26 0.4× 11 318
Nanhong Tang China 11 211 1.5× 102 1.0× 173 1.9× 80 1.0× 68 1.0× 18 391

Countries citing papers authored by Yue Shao

Since Specialization
Citations

This map shows the geographic impact of Yue Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Shao more than expected).

Fields of papers citing papers by Yue Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Shao. The network helps show where Yue Shao may publish in the future.

Co-authorship network of co-authors of Yue Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Shao. A scholar is included among the top collaborators of Yue Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Shao. Yue Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Hao, Yue Shao, Zhenghao Li, et al.. (2025). Prognostic prediction of long-term survival in patients with type A aortic dissection undergoing surgical repair: development of a novel prognostic index. BMC Cardiovascular Disorders. 25(1). 99–99. 1 indexed citations
4.
Li, Changying, Lingwen Kong, Yue Shao, et al.. (2024). Integrated analyses of Mendelian randomization, eQTL, and single-cell transcriptome identify CCN3 as a potential biomarker in aortic dissection. Scientific Reports. 14(1). 32062–32062.
5.
Pearce, Stuart, Qishan Chen, Jun Luo, et al.. (2023). Causal Role for Neutrophil Elastase in Thoracic Aortic Dissection in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 43(10). 1900–1920. 11 indexed citations
6.
Zhang, Cheng, et al.. (2023). Identification of key biomarkers and immune infiltration in the thoracic acute aortic dissection by bioinformatics analysis. BMC Cardiovascular Disorders. 23(1). 75–75. 3 indexed citations
7.
Tang, Xia, Lei Xiang, Qingshu Li, et al.. (2023). Molecular evolution in different subtypes of multifocal hepatocellular carcinoma. Hepatology International. 17(6). 1429–1443. 1 indexed citations
8.
Luo, Jun, Yujing Liu, Changzhu Duan, et al.. (2023). SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway. Cellular Signalling. 114. 110997–110997. 3 indexed citations
9.
Shao, Yue, et al.. (2022). Impacts of eosinophil percentage on prognosis acute type A aortic dissection patients. BMC Cardiovascular Disorders. 22(1). 146–146. 6 indexed citations
10.
Liu, Ye, et al.. (2022). Elevated Blood Urea Nitrogen to Serum Albumin Ratio Is an Adverse Prognostic Predictor for Patients Undergoing Cardiac Surgery. Frontiers in Cardiovascular Medicine. 9. 888736–888736. 16 indexed citations
11.
12.
Shao, Yue, et al.. (2021). Construction and Integrated Analysis of Competitive Endogenous Long Non-Coding RNA Network in Thoracic Aortic Dissection. International Journal of General Medicine. Volume 14. 6863–6873. 3 indexed citations
13.
Shao, Yue, et al.. (2021). Survival benefit of perioperative chemotherapy for T1–3N0M0 stage esophageal cancer: a SEER database analysis. Journal of Thoracic Disease. 13(2). 995–1004. 4 indexed citations
14.
Shao, Yue, et al.. (2021). Nutritional indices at admission are associated with mortality rates of patients in the intensive care unit. European Journal of Clinical Nutrition. 76(4). 557–563. 14 indexed citations
15.
Dong, Dan, Ning Wei, Mingli Sun, et al.. (2019). Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Biomedicine & Pharmacotherapy. 111. 917–925. 53 indexed citations
16.
Gao, Jian, Qianqian Zheng, Yue Shao, Wei Wang, & Chenghai Zhao. (2018). CD155 downregulation synergizes with adriamycin to induce breast cancer cell apoptosis. APOPTOSIS. 23(9-10). 512–520. 24 indexed citations
17.
Sun, Jiazheng, Jing Zhang, Yue Shao, et al.. (2018). Protective effects of ginsenoside Rg1 on splenocytes and thymocytes in an aging rat model induced by d-galactose. International Immunopharmacology. 58. 94–102. 49 indexed citations
18.
Dong, Dan, et al.. (2017). Prognostic value of long noncoding RNA ZFAS1 in various carcinomas: a meta-analysis. Oncotarget. 8(48). 84497–84505. 6 indexed citations
19.
Popat, Sanjay, Dan Zhao, Hongchao Pan, et al.. (2006). A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer. Annals of Oncology. 17(12). 1810–1817. 48 indexed citations
20.
Mueller, Christoph, Yue Shao, H. J. Altermatt, M. W. Hess, & J Shelby. (1993). THE EFFECT OF CYCLOSPORINE TREATMENT ON THE EXPRESSION OF GENES ENCODING GRANZYME A AND PERFORIN IN THE INFILTRATE OF MOUSE HEART TRANSPLANTS. Transplantation. 55(1). 139–145. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026